289 related articles for article (PubMed ID: 20811278)
1. Front-line management of diffuse large B cell lymphoma.
Cabanillas F
Curr Opin Oncol; 2010 Nov; 22(6):642-5. PubMed ID: 20811278
[TBL] [Abstract][Full Text] [Related]
2. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Fabbri A; Gozzetti A; Rigacci L
Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
[No Abstract] [Full Text] [Related]
3. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
[TBL] [Abstract][Full Text] [Related]
4. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
[TBL] [Abstract][Full Text] [Related]
5. Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP.
Testoni M; Kwee I; Greiner TC; Montes-Moreno S; Vose J; Chan WC; Chiappella A; Baldini L; Ferreri AJ; Gaidano G; Mian M; Zucca E; Bertoni F
Br J Haematol; 2011 Oct; 155(2):274-7. PubMed ID: 21488860
[No Abstract] [Full Text] [Related]
6. Radiation therapy after R-CHOP for diffuse large B-cell lymphoma: the gain remains.
Yahalom J
J Clin Oncol; 2010 Sep; 28(27):4105-7. PubMed ID: 20713874
[No Abstract] [Full Text] [Related]
7. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
Akhtar S; Maghfoor I
N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
[No Abstract] [Full Text] [Related]
8. Richter's transformation of chronic lymphocytic leukemia.
Giardino AA; O'Regan K; Jagannathan JP; Elco C; Ramaiya N; Lacasce A
J Clin Oncol; 2011 Apr; 29(10):e274-6. PubMed ID: 21220587
[No Abstract] [Full Text] [Related]
9. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2005 Jun; (13):1-18. PubMed ID: 16135258
[No Abstract] [Full Text] [Related]
10. Inappropriate antidiuretic hormone production in diffuse large B-cell lymphoma.
Kobayashi K; Yokote T; Akioka T; Takubo T; Tsuji M; Hanafusa T
Br J Haematol; 2008 Oct; 143(1):2. PubMed ID: 18513282
[No Abstract] [Full Text] [Related]
11. Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary.
Ahbeddou N; Fetohi M; Khanoussi BE; Errihani H
Arch Gynecol Obstet; 2011 May; 283(5):1173-4. PubMed ID: 20957380
[No Abstract] [Full Text] [Related]
12. Improving outcomes for patients with diffuse large B-cell lymphoma.
Flowers CR; Sinha R; Vose JM
CA Cancer J Clin; 2010; 60(6):393-408. PubMed ID: 21030533
[TBL] [Abstract][Full Text] [Related]
13. Relevance of the International Prognostic Index in the rituximab era.
Tay K; Tai D; Tao M; Quek R; Ha TC; Lim ST
J Clin Oncol; 2011 Jan; 29(1):e14; author reply e15. PubMed ID: 21115864
[No Abstract] [Full Text] [Related]
14. [Standard or up-to-date treatment for high risk, relapsed and refractory DLBCL].
Kagami Y
Rinsho Ketsueki; 2010 Oct; 51(10):1409-16. PubMed ID: 20962474
[No Abstract] [Full Text] [Related]
15. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].
Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Jyomen Y; Tomaru U
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2589-92. PubMed ID: 24335377
[TBL] [Abstract][Full Text] [Related]
16. Therapy of diffuse large B-cell lymphomas.
Pfreundschuh M
Eur J Cancer; 2009 Sep; 45 Suppl 1():386-7. PubMed ID: 19775641
[No Abstract] [Full Text] [Related]
17. Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome.
Dozzo M; Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Mazzucco M; Perali G; Fanin R
Am J Hematol; 2014 Oct; 89(10):1011-3. PubMed ID: 24912474
[No Abstract] [Full Text] [Related]
18. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
19. CHOP and rituximab in elderly patients.
Portlock CS
Curr Oncol Rep; 2002 Sep; 4(5):414. PubMed ID: 12162916
[No Abstract] [Full Text] [Related]
20. Primary diffuse large B-cell lymphoma of the mandible. A case report.
Pié-Sánchez J; Petit J; Figueiredo R; Gay-Escoda C
Minerva Stomatol; 2011; 60(1-2):87-92. PubMed ID: 21252853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
